Workshop on shedding data from gene therapy studies with viral vectors. Amsterdam, January 22, 2004

被引:3
作者
Bleijs, DA [1 ]
机构
[1] Netherlands Commiss Genet Modificat, NL-3720 AN Bilthoven, Netherlands
关键词
gene therapy; shedding; biodistribution; viral vectors; biosafety; risk analysis;
D O I
10.1002/jgm.689
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:256 / 259
页数:4
相关论文
共 5 条
[1]   Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males [J].
Arruda, VR ;
Fields, PA ;
Milner, R ;
Wainwright, L ;
De Miguel, MP ;
Donovan, PJ ;
Herzog, RW ;
Nichols, TC ;
Biegel, JA ;
Razavi, M ;
Dake, M ;
Huff, D ;
Flake, AW ;
Couto, L ;
Kay, MA ;
High, KA .
MOLECULAR THERAPY, 2001, 4 (06) :586-592
[2]   Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle [J].
Favre, D ;
Provost, N ;
Blouin, V ;
Blacho, G ;
Chérel, Y ;
Salvetti, A ;
Moullier, P .
MOLECULAR THERAPY, 2001, 4 (06) :559-566
[3]   LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 [J].
Hacein-Bey-Abina, S ;
Von Kalle, C ;
Schmidt, M ;
McCcormack, MP ;
Wulffraat, N ;
Leboulch, P ;
Lim, A ;
Osborne, CS ;
Pawliuk, R ;
Morillon, E ;
Sorensen, R ;
Forster, A ;
Fraser, P ;
Cohen, JI ;
de Saint Basile, G ;
Alexander, I ;
Wintergerst, U ;
Frebourg, T ;
Aurias, A ;
Stoppa-Lyonnet, D ;
Romana, S ;
Radford-Weiss, I ;
Gross, F ;
Valensi, F ;
Delabesse, E ;
Macintyre, E ;
Sigaux, F ;
Soulier, J ;
Leiva, LE ;
Wissler, M ;
Prinz, C ;
Rabbitts, TH ;
Le Deist, F ;
Fischer, A ;
Cavazzana-Calvo, M .
SCIENCE, 2003, 302 (5644) :415-419
[4]   AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B [J].
Manno, CS ;
Chew, AJ ;
Hutchison, S ;
Larson, PJ ;
Herzog, RW ;
Arruda, VP ;
Tai, SJ ;
Ragni, MV ;
Thompson, A ;
Ozelo, M ;
Couto, LB ;
Leonard, DGB ;
Johnson, FA ;
McClelland, A ;
Scallan, C ;
Skarsgard, E ;
Flake, AW ;
Kay, MA ;
High, KA ;
Glader, B .
BLOOD, 2003, 101 (08) :2963-2972
[5]   Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency [J].
McCormack, MP ;
Rabbitts, TH .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) :913-922